AU2009905549A0 - Antisense Molecules and Methods for Treating Pathologies - Google Patents

Antisense Molecules and Methods for Treating Pathologies

Info

Publication number
AU2009905549A0
AU2009905549A0 AU2009905549A AU2009905549A AU2009905549A0 AU 2009905549 A0 AU2009905549 A0 AU 2009905549A0 AU 2009905549 A AU2009905549 A AU 2009905549A AU 2009905549 A AU2009905549 A AU 2009905549A AU 2009905549 A0 AU2009905549 A0 AU 2009905549A0
Authority
AU
Australia
Prior art keywords
methods
antisense molecules
treating pathologies
pathologies
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009905549A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Western Australia
Original Assignee
University of Western Australia
Filing date
Publication date
Application filed by University of Western Australia filed Critical University of Western Australia
Publication of AU2009905549A0 publication Critical patent/AU2009905549A0/en
Priority to KR1020237000150A priority Critical patent/KR102581868B1/en
Priority to AU2010317599A priority patent/AU2010317599B2/en
Priority to BR112012011195-7A priority patent/BR112012011195B1/en
Priority to DK10829367.1T priority patent/DK2499249T3/en
Priority to CN2010800613405A priority patent/CN103003430A/en
Priority to KR1020237031960A priority patent/KR20230137491A/en
Priority to PL10829367T priority patent/PL2499249T3/en
Priority to KR1020127015085A priority patent/KR101958491B1/en
Priority to IL297299A priority patent/IL297299A/en
Priority to KR1020197019966A priority patent/KR102113306B1/en
Priority to NZ626359A priority patent/NZ626359A/en
Priority to KR1020207013603A priority patent/KR102239374B1/en
Priority to KR1020227005476A priority patent/KR102487132B1/en
Priority to US13/509,331 priority patent/US8637483B2/en
Priority to HUE10829367A priority patent/HUE040445T2/en
Priority to PT10829367T priority patent/PT2499249T/en
Priority to NZ716534A priority patent/NZ716534A/en
Priority to PCT/AU2010/001520 priority patent/WO2011057350A1/en
Priority to EP18179910.7A priority patent/EP3431603A1/en
Priority to CA2780563A priority patent/CA2780563A1/en
Priority to KR1020217010259A priority patent/KR102366851B1/en
Priority to BR122023023194-5A priority patent/BR122023023194A2/en
Priority to RS20181351A priority patent/RS58079B1/en
Priority to CN201610091098.5A priority patent/CN105838714B/en
Priority to TR2018/16523T priority patent/TR201816523T4/en
Priority to KR1020177033869A priority patent/KR102000762B1/en
Priority to JP2012538147A priority patent/JP5963678B2/en
Priority to EP10829367.1A priority patent/EP2499249B1/en
Priority to LTEP10829367.1T priority patent/LT2499249T/en
Priority to IL314343A priority patent/IL314343A/en
Priority to SI201031797T priority patent/SI2499249T1/en
Priority to ES10829367.1T priority patent/ES2693459T3/en
Priority to IL219753A priority patent/IL219753A/en
Priority to US14/108,137 priority patent/US9228187B2/en
Priority to US14/944,886 priority patent/US9758783B2/en
Priority to AU2016202924A priority patent/AU2016202924A1/en
Priority to JP2016127827A priority patent/JP6294393B2/en
Priority to US15/661,750 priority patent/US10287586B2/en
Priority to IL255707A priority patent/IL255707B/en
Priority to JP2018001970A priority patent/JP6525449B2/en
Priority to AU2018202105A priority patent/AU2018202105A1/en
Priority to HRP20181824TT priority patent/HRP20181824T1/en
Priority to CY20181101163T priority patent/CY1121198T1/en
Priority to IL264525A priority patent/IL264525A/en
Priority to US16/357,918 priority patent/US10781450B2/en
Priority to JP2019077083A priority patent/JP6936830B2/en
Priority to US16/993,116 priority patent/US11447776B2/en
Priority to IL276947A priority patent/IL276947A/en
Priority to AU2020260498A priority patent/AU2020260498A1/en
Priority to JP2021139342A priority patent/JP2022001053A/en
Priority to US17/817,588 priority patent/US20230063394A1/en
Priority to AU2023203103A priority patent/AU2023203103A1/en
Priority to JP2024007295A priority patent/JP2024029262A/en
Abandoned legal-status Critical Current

Links

AU2009905549A 2009-11-12 2009-11-12 Antisense Molecules and Methods for Treating Pathologies Abandoned AU2009905549A0 (en)

Priority Applications (53)

Application Number Priority Date Filing Date Title
KR1020237000150A KR102581868B1 (en) 2009-11-12 2010-11-12 Antisense Molecules and Methods for Treating Pathologies
AU2010317599A AU2010317599B2 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
BR112012011195-7A BR112012011195B1 (en) 2009-11-12 2010-11-12 ANTISENSE OLIGONUCLEOTIDE, PHARMACEUTICAL COMPOSITION AND USE OF A PHARMACEUTICAL COMPOSITION
DK10829367.1T DK2499249T3 (en) 2009-11-12 2010-11-12 ANTISENCE MOLECULES AND PROCEDURES FOR TREATING PATHOLOGIES
CN2010800613405A CN103003430A (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
KR1020237031960A KR20230137491A (en) 2009-11-12 2010-11-12 Antisense Molecules and Methods for Treating Pathologies
PL10829367T PL2499249T3 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
KR1020127015085A KR101958491B1 (en) 2009-11-12 2010-11-12 Antisense Molecules and Methods for Treating Pathologies
IL297299A IL297299A (en) 2009-11-12 2010-11-12 Antisense oligonucleotides for inducing exon skipping in the dystrophin gene
KR1020197019966A KR102113306B1 (en) 2009-11-12 2010-11-12 Antisense Molecules and Methods for Treating Pathologies
NZ626359A NZ626359A (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
KR1020207013603A KR102239374B1 (en) 2009-11-12 2010-11-12 Antisense Molecules and Methods for Treating Pathologies
KR1020227005476A KR102487132B1 (en) 2009-11-12 2010-11-12 Antisense Molecules and Methods for Treating Pathologies
US13/509,331 US8637483B2 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
HUE10829367A HUE040445T2 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
PT10829367T PT2499249T (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
NZ716534A NZ716534A (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
PCT/AU2010/001520 WO2011057350A1 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
EP18179910.7A EP3431603A1 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
CA2780563A CA2780563A1 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
KR1020217010259A KR102366851B1 (en) 2009-11-12 2010-11-12 Antisense Molecules and Methods for Treating Pathologies
BR122023023194-5A BR122023023194A2 (en) 2009-11-12 2010-11-12 ANTISENSE OLIGONUCLEOTIDE, COMPOSITION AND RESPECTIVE USE
RS20181351A RS58079B1 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
CN201610091098.5A CN105838714B (en) 2009-11-12 2010-11-12 Antisense molecules and methods of treating diseases
TR2018/16523T TR201816523T4 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for the treatment of pathologies.
KR1020177033869A KR102000762B1 (en) 2009-11-12 2010-11-12 Antisense Molecules and Methods for Treating Pathologies
JP2012538147A JP5963678B2 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating disease states
EP10829367.1A EP2499249B1 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
LTEP10829367.1T LT2499249T (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
IL314343A IL314343A (en) 2009-11-12 2010-11-12 Antisense oligonucleotides for inducing exon skipping in the dystrophin gene
SI201031797T SI2499249T1 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for treating pathologies
ES10829367.1T ES2693459T3 (en) 2009-11-12 2010-11-12 Antisense molecules and methods for the treatment of pathologies
IL219753A IL219753A (en) 2009-11-12 2012-05-13 Antisense oligonucleotides for inducing exon skipping in the dystrophin gene
US14/108,137 US9228187B2 (en) 2009-11-12 2013-12-16 Antisense molecules and methods for treating pathologies
US14/944,886 US9758783B2 (en) 2009-11-12 2015-11-18 Antisense molecules and methods for treating pathologies
AU2016202924A AU2016202924A1 (en) 2009-11-12 2016-05-06 Antisense molecules and methods for treating pathologies
JP2016127827A JP6294393B2 (en) 2009-11-12 2016-06-28 Antisense molecules and methods for treating disease states
US15/661,750 US10287586B2 (en) 2009-11-12 2017-07-27 Antisense molecules and methods for treating pathologies
IL255707A IL255707B (en) 2009-11-12 2017-11-15 Antisense oligonucleotides for inducing exon skipping in the dystrophin gene
JP2018001970A JP6525449B2 (en) 2009-11-12 2018-01-10 Antisense molecules and methods for treating medical conditions
AU2018202105A AU2018202105A1 (en) 2009-11-12 2018-03-23 Antisense Molecules and Methods for Treating Pathologies
HRP20181824TT HRP20181824T1 (en) 2009-11-12 2018-10-31 Antisense molecules and methods for treating pathologies
CY20181101163T CY1121198T1 (en) 2009-11-12 2018-11-07 ANTI-TERMINAL MOLECULES AND METHODS FOR THE TREATMENT OF PATHOLOGIES
IL264525A IL264525A (en) 2009-11-12 2019-01-29 Antisense oligonucleotides for inducing exon skipping in the dystrophin gene
US16/357,918 US10781450B2 (en) 2009-11-12 2019-03-19 Antisense molecules and methods for treating pathologies
JP2019077083A JP6936830B2 (en) 2009-11-12 2019-04-15 Antisense molecules and methods for treating medical conditions
US16/993,116 US11447776B2 (en) 2009-11-12 2020-08-13 Antisense molecules and methods for treating pathologies
IL276947A IL276947A (en) 2009-11-12 2020-08-26 Antisense oligonucleotides for inducing exon skipping in the dystrophin gene
AU2020260498A AU2020260498A1 (en) 2009-11-12 2020-10-29 Antisense Molecules and Methods for Treating Pathologies
JP2021139342A JP2022001053A (en) 2009-11-12 2021-08-27 Antisense molecules and methods for treating pathologies
US17/817,588 US20230063394A1 (en) 2009-11-12 2022-08-04 Antisense molecules and methods for treating pathologies
AU2023203103A AU2023203103A1 (en) 2009-11-12 2023-05-17 Antisense Molecules and Methods for Treating Pathologies
JP2024007295A JP2024029262A (en) 2009-11-12 2024-01-22 Antisense molecules and methods for treating pathologies

Publications (1)

Publication Number Publication Date
AU2009905549A0 true AU2009905549A0 (en) 2009-11-26

Family

ID=

Similar Documents

Publication Publication Date Title
HRP20181824T1 (en) Antisense molecules and methods for treating pathologies
PL2442814T3 (en) Bifidobacteria for treating diabetes and related conditions
IL207752A0 (en) Methods of treating inflammation
IL218544A0 (en) Dll4-binding molecules
WO2011090666A9 (en) Methods for treating autism
GB0815109D0 (en) Polydialkylsiloxane-bridged bi-photochromic molecules
IL212348A0 (en) Treatment method
IL208354A0 (en) Methods of treatment
ZA201103892B (en) Glycerol treatment process
EP2331564A4 (en) Methods of treating inflammation
ZA201107447B (en) Treated tobacco
EP2470565A4 (en) Modified variable domain molecules and methods for producing and using same
EP2313347A4 (en) Novel systems and methods for wastewater treatment
GB2486158B (en) In-line characterization
EP2240192A4 (en) Treatment for dermatological conditions
EP2493918A4 (en) Improved neurturin molecules
GB0903562D0 (en) RNA molecules
AU2009902653A0 (en) Antisense molecules and methods for treating SMN-related pathologies
AU2009905549A0 (en) Antisense Molecules and Methods for Treating Pathologies
AU2010902532A0 (en) Antisense molecules and methods for treating SMN-related pathologies
AU2011902304A0 (en) Antisense Molecules and Methods for Treating SMN-related Pathologies
AU2012902430A0 (en) Antisense Molecules and Methods for Treating SMN-related Pathologies
GB0809181D0 (en) Inter-trading process and system
GB0913579D0 (en) Catalst and process
GB0915520D0 (en) Molecules